This kit uses RT-PCR to detect New Delhi metallo-beta-lactamase 1 (NDM-1) in nasopharyngeal and/or oropharyngeal swabs, stool, serum, plasma, and other samples. Test results may serve as a reference for clincial evaluation of NDM-1.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaenously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.